These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31839435)

  • 21. Is R1 vascular hepatectomy for hepatocellular carcinoma oncologically adequate? Analysis of 327 consecutive patients.
    Donadon M; Terrone A; Procopio F; Cimino M; Palmisano A; Viganò L; Del Fabbro D; Di Tommaso L; Torzilli G
    Surgery; 2019 May; 165(5):897-904. PubMed ID: 30691871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases.
    Brudvik KW; Mise Y; Chung MH; Chun YS; Kopetz SE; Passot G; Conrad C; Maru DM; Aloia TA; Vauthey JN
    Ann Surg Oncol; 2016 Aug; 23(8):2635-43. PubMed ID: 27016292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival.
    Andreou A; Knitter S; Schmelzle M; Kradolfer D; Maurer MH; Auer TA; Fehrenbach U; Lachenmayer A; Banz V; Schöning W; Candinas D; Pratschke J; Beldi G
    Surgery; 2021 May; 169(5):1061-1068. PubMed ID: 33386128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors differ according to KRAS mutational status: A classification and regression tree model to define prognostic groups after hepatectomy for colorectal liver metastasis.
    Moro A; Mehta R; Tsilimigras DI; Sahara K; Paredes AZ; Bagante F; Guglielmi A; Alexandrescu S; Poultsides GA; Sasaki K; Aucejo FN; Pawlik TM
    Surgery; 2020 Sep; 168(3):497-503. PubMed ID: 32675031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic impact of resection margin status varies according to the genetic and morphological evaluation (GAME) score for colorectal liver metastasis.
    Wang HW; Wang LJ; Jin KM; Bao Q; Li J; Wang K; Xing BC
    J Surg Oncol; 2021 Sep; 124(4):619-626. PubMed ID: 34081792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases.
    Margonis GA; Buettner S; Andreatos N; Sasaki K; Ijzermans JNM; van Vugt JLA; Pawlik TM; Choti MA; Cameron JL; He J; Wolfgang CL; Weiss MJ
    Ann Surg; 2017 Oct; 266(4):641-649. PubMed ID: 28657938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Prognostic Impact of KRAS Mutation in Patients Having Curative Resection of Synchronous Colorectal Liver Metastases.
    Goffredo P; Utria AF; Beck AC; Chun YS; Howe JR; Weigel RJ; Vauthey JN; Hassan I
    J Gastrointest Surg; 2019 Oct; 23(10):1957-1963. PubMed ID: 30276588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgery for colorectal liver metastases: the impact of resection margins on recurrence and overall survival.
    Angelsen JH; Horn A; Eide GE; Viste A
    World J Surg Oncol; 2014 Apr; 12():127. PubMed ID: 24767422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis on prognostic value of KRAS mutation in resected mass-forming cholangiocarcinoma.
    Procopio F; Branciforte B; Nappo G; Di Tommaso L; Lleo A; Torzilli G
    Eur J Surg Oncol; 2022 Jul; 48(7):1455-1463. PubMed ID: 35317947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An invited commentary on the article "Microscopic resection margins adversely influence survival rates after surgery for colorectal liver metastases: An open ambidirectional cohort study".
    Karimian F
    Int J Surg; 2020 Dec; 84():100-101. PubMed ID: 33129995
    [No Abstract]   [Full Text] [Related]  

  • 31. Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review.
    Moris D; Ronnekleiv-Kelly S; Rahnemai-Azar AA; Felekouras E; Dillhoff M; Schmidt C; Pawlik TM
    J Gastrointest Surg; 2017 Jun; 21(6):1076-1085. PubMed ID: 28364212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of R1 resection for colorectal liver metastases on local recurrence and overall survival in the era of modern chemotherapy: An analysis of 1,428 resection areas.
    Ardito F; Panettieri E; Vellone M; Ferrucci M; Coppola A; Silvestrini N; Arena V; Adducci E; Capelli G; Vecchio FM; Giovannini I; Nuzzo G; Giuliante F
    Surgery; 2019 Apr; 165(4):712-720. PubMed ID: 30482518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of K-RAS mutational status and primary tumor location in patients undergoing resection for colorectal cancer liver metastases: an update.
    O Connor JM; Sanchez Loria F; Ardiles V; Grondona J; Sanchez P; Andriani O; Fauda M; Brancato F; Huertas E; Alvarez F; de Santibañes E
    Future Oncol; 2019 Sep; 15(27):3149-3157. PubMed ID: 31426677
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of anatomical liver resection on patient survival in KRAS-wild-type colorectal liver metastasis: A multicenter retrospective study.
    Kawai T; Ishii T; Uchida Y; Sato A; Naito S; Kitaguchi K; Komatsubara T; Nakamura I; Ogiso S; Fukumitsu K; Seo S; Fujikawa T; Yasuchika K; Hirose T; Zaima M; Taura K; Hatano E; Terajima H
    Surgery; 2022 Oct; 172(4):1133-1140. PubMed ID: 35965146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of R1 Resection for Advanced Colorectal Liver Metastases in the Era of Modern Effective Chemotherapy.
    Laurent C; Adam JP; Denost Q; Smith D; Saric J; Chiche L
    World J Surg; 2016 May; 40(5):1191-9. PubMed ID: 26757718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis.
    Passiglia F; Bronte G; Bazan V; Galvano A; Vincenzi B; Russo A
    Crit Rev Oncol Hematol; 2016 Mar; 99():150-7. PubMed ID: 26775732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of positive surgical margins after resection of colorectal cancer liver metastases: reappraisal in the era of modern chemotherapy.
    Tranchart H; Chirica M; Faron M; Balladur P; Lefevre LB; Svrcek M; de Gramont A; Tiret E; Paye F
    World J Surg; 2013 Nov; 37(11):2647-54. PubMed ID: 23982776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.
    Sasaki K; Margonis GA; Wilson A; Kim Y; Buettner S; Andreatos N; Gani F; Amini N; Spolverato G; Pawlik TM
    Ann Surg Oncol; 2016 Oct; 23(11):3736-3743. PubMed ID: 27352204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.
    Okuno M; Goumard C; Kopetz S; Vega EA; Joechle K; Mizuno T; Omichi K; Tzeng CD; Chun YS; Vauthey JN; Conrad C
    Ann Surg Oncol; 2018 Aug; 25(8):2457-2466. PubMed ID: 29786130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis.
    Kim HS; Heo JS; Lee J; Lee JY; Lee MY; Lim SH; Lee WY; Kim SH; Park YA; Cho YB; Yun SH; Kim ST; Park JO; Lim HY; Choi YS; Kwon WI; Kim HC; Park YS
    BMC Cancer; 2016 Feb; 16():120. PubMed ID: 26887348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.